Goodwin advised OKRA.ai on the deal. Bird & Bird and Ropes & Gray advised Envision Pharma Group. OKRA.ai announced their acquisition by Envision Pharma Group (Envision). Envision...
You must be a Standard 1 Year member to access this content.
Bird & Bird has advised the Dementia Discovery Fund on the deal. The investment will enable Amphista to accelerate the application of its technology into indications...
You must be a Standard 1 Year member to access this content.
Bird & Bird has collaborated with U.S. law firm Smith Anderson to advise Catalyst Clinical Research LLC. The Aptus sellers were advised by the global law...
You must be a Standard 1 Year member to access this content.
Ashfords advised life sciences company Iksuda Therapeutics on the deal. Bird & Bird advised Mirae Asset Capital, Celltrion and Premier Partners. Iksuda is the developer of...
You must be a Standard 1 Year member to access this content.
Ashfords advised life sciences company Iksuda Therapeutics on the deal. Bird & Bird advised Mirae Asset Capital, Celltrion and Premier Partners. Iksuda is the developer of...
You must be a Standard 1 Year member to access this content.
